Psychopharmacology in the Elderly Person with Cardiovascular Disease
Comparative risk of QT interval corrected for heart rate (QTc)... | Download Table
Managing cardiovascular disease risk in patients treated with antipsyc | JMDH
Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system - ScienceDirect
Antipsychotics cardiotoxicity: What's known and what's next
Cardiac Effects of Antipsychotics: QTc Prolongation - Psychopharmacology Institute
Cardiac Issues and Antipsychotics. | Download Scientific Diagram
Forest plot showing the hazard ratios of ischemic heart disease for... | Download Scientific Diagram
![PDF] Atypical antipsychotics, schizophrenia, and cardiovascular risk: What family physicians need to know | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/408d7c481b7be07b9eb4decd1871208a4aa65032/5-Table2-1.png "PDF] Atypical antipsychotics, schizophrenia, and cardiovascular risk: What family physicians need to know | Semantic Scholar")
PDF] Atypical antipsychotics, schizophrenia, and cardiovascular risk: What family physicians need to know | Semantic Scholar
Introduction to Antipsychotics - PsychDB
Clinical Feature: Dyslipidemia & Antipsychotic Medications: Who is Monitoring the Lipids? | National Lipid Association Online
Antipsychotics cardiotoxicity: What's known and what's next
![PDF] Atypical antipsychotics, schizophrenia, and cardiovascular risk: What family physicians need to know | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/408d7c481b7be07b9eb4decd1871208a4aa65032/5-Table1-1.png "PDF] Atypical antipsychotics, schizophrenia, and cardiovascular risk: What family physicians need to know | Semantic Scholar")
PDF] Atypical antipsychotics, schizophrenia, and cardiovascular risk: What family physicians need to know | Semantic Scholar
Cardiovascular adverse effects of psychotropics: What to look for | MDedge Psychiatry
Atypical antipsychotics, schizophrenia, and cardiovascular risk: What family physicians need to know | British Columbia Medical Journal
Neurology International | Free Full-Text | Antipsychotic Polypharmacy-Related Cardiovascular Morbidity and Mortality: A Comprehensive Review
Frontiers | Cardiovascular Risk of Concomitant Use of Atypical Antipsychotics and Stimulants Among Commercially Insured Youth in the United States
Sudden cardiac death and antipsychotics Part 2: Monitoring and prevention | Advances in Psychiatric Treatment | Cambridge Core
Understanding and managing cardiac side-effects of second-generation antipsychotics in the treatment of schizophrenia | BJPsych Advances | Cambridge Core
Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice - ScienceDirect
Biomedicines | Free Full-Text | Seventy Years of Antipsychotic Development: A Critical Review
A systematic review of antipsychotic drug effects on human gene expression related to risk factors for cardiovascular disease | The Pharmacogenomics Journal
Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps - ScienceDirect
Managing cardiovascular disease risk in patients treated with antipsyc | JMDH
